CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1

CIBMTR Reporting Implementation Guide - Local Development build (v0.1.6). See the Directory of published versions

Example Medication: Medication-Post-HCT-Disease-Therapy-Example

Generated Narrative: Medication

Resource Medication "Medication-Post-HCT-Disease-Therapy-Example"

Profile: CIBMTR Planned Post-HCT Disease Therapy Medication

Security Labels: http://terminology.cibmtr.org/codesystem/transplant-center

code: blinatumomab (RxNorm#1597258; RxNorm#1597260 "blinatumomab Injectable Product"; RxNorm#1597262 "blinatumomab 0.035 MG Injection"; RxNorm#1597267 "blinatumomab 0.035 MG Injection [Blincyto]"; RxNorm#1651249 "blinatumomab 0.035 MG"; RxNorm#1651250 "blinatumomab Injection"; RxNorm#1651252 "blinatumomab 0.035 MG [Blincyto]"; RxNorm#1651253 "blinatumomab Injection [Blincyto]")

Ingredients

-Item[x]Strength
*blinatumomab (RxNorm#1597258; RxNorm#1597260 "blinatumomab Injectable Product"; RxNorm#1597262 "blinatumomab 0.035 MG Injection"; RxNorm#1597267 "blinatumomab 0.035 MG Injection [Blincyto]"; RxNorm#1651249 "blinatumomab 0.035 MG"; RxNorm#1651250 "blinatumomab Injection"; RxNorm#1651252 "blinatumomab 0.035 MG [Blincyto]"; RxNorm#1651253 "blinatumomab Injection [Blincyto]")0.035 milligram (Details: UCUM code mg = 'mg')/0.035 milligram (Details: UCUM code mg = 'mg')